Review
Open access
Oct 2026
Efficacy and Safety of CagriSema in Type 2 Diabetes: A Dose- and Comparator-Specific Systematic Review and Bayesian Meta-Analysis.
CagriSema provides substantial glycaemic and body-weight benefits versus placebo and is more evident for body-weight reduction, while comparative gastrointestinal tolerability and discontinuation risk remain uncertain.
C. S. Kow, A. F. Zaihan, D. Ramachandram et al.
· Diabetes, obesity and metabo... · 0 citations